#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kyle Kuvalanka Email
CFO and CBO . ROME Therapeutics
How to contact Kyle Kuvalanka
Join and see Kyle's contact info for free!Current Roles
Employees:
73Revenue:
$11.3MAbout
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.†With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.ROME Therapeutics Address
201 Brookline AveCambridge, MA
United States